Multidisciplinary rehabilitation for older people with hip fractures

Helen Hg Handoll, Ian D Cameron, Jenson Cs Mak, Claire E Panagoda, Terence P Finnegan, Helen Hg Handoll, Ian D Cameron, Jenson Cs Mak, Claire E Panagoda, Terence P Finnegan

Abstract

Background: Hip fracture is a major cause of morbidity and mortality in older people, and its impact on society is substantial. After surgery, people require rehabilitation to help them recover. Multidisciplinary rehabilitation is where rehabilitation is delivered by a multidisciplinary team, supervised by a geriatrician, rehabilitation physician or other appropriate physician. This is an update of a Cochrane Review first published in 2009.

Objectives: To assess the effects of multidisciplinary rehabilitation, in either inpatient or ambulatory care settings, for older people with hip fracture.

Search methods: We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, CENTRAL, MEDLINE and Embase (October 2020), and two trials registers (November 2019).

Selection criteria: We included randomised and quasi-randomised trials of post-surgical care using multidisciplinary rehabilitation of older people (aged 65 years or over) with hip fracture. The primary outcome - 'poor outcome' - was a composite of mortality and decline in residential status at long-term (generally one year) follow-up. The other 'critical' outcomes were health-related quality of life, mortality, dependency in activities of daily living, mobility, and related pain.

Data collection and analysis: Pairs of review authors independently performed study selection, assessed risk of bias and extracted data. We pooled data where appropriate and used GRADE for assessing the certainty of evidence for each outcome.

Main results: The 28 included trials involved 5351 older (mean ages ranged from 76.5 to 87 years), usually female, participants who had undergone hip fracture surgery. There was substantial clinical heterogeneity in the trial interventions and populations. Most trials had unclear or high risk of bias for one or more items, such as blinding-related performance and detection biases. We summarise the findings for three comparisons below. Inpatient rehabilitation: multidisciplinary rehabilitation versus 'usual care' Multidisciplinary rehabilitation was provided primarily in an inpatient setting in 20 trials. Multidisciplinary rehabilitation probably results in fewer cases of 'poor outcome' (death or deterioration in residential status, generally requiring institutional care) at 6 to 12 months' follow-up (risk ratio (RR) 0.88, 95% confidence interval (CI) 0.80 to 0.98; 13 studies, 3036 participants; moderate-certainty evidence). Based on an illustrative risk of 347 people with hip fracture with poor outcome in 1000 people followed up between 6 and 12 months, this equates to 41 (95% CI 7 to 69) fewer people with poor outcome after multidisciplinary rehabilitation. Expressed in terms of numbers needed to treat for an additional harmful outcome (NNTH), 25 patients (95% CI 15 to 100) would need to be treated to avoid one 'poor outcome'. Subgroup analysis by type of multidisciplinary rehabilitation intervention showed no evidence of subgroup differences. Multidisciplinary rehabilitation may result in fewer deaths in hospital but the confidence interval does not exclude a small increase in the number of deaths (RR 0.77, 95% CI 0.58 to 1.04; 11 studies, 2455 participants; low-certainty evidence). A similar finding applies at 4 to 12 months' follow-up (RR 0.91, 95% CI 0.80 to 1.05; 18 studies, 3973 participants; low-certainty evidence). Multidisciplinary rehabilitation may result in fewer people with poorer mobility at 6 to 12 months' follow-up (RR 0.83, 95% CI 0.71 to 0.98; 5 studies, 1085 participants; low-certainty evidence). Due to very low-certainty evidence, we have little confidence in the findings for marginally better quality of life after multidisciplinary rehabilitation (1 study). The same applies to the mixed findings of some or no difference from multidisciplinary rehabilitation on dependence in activities of daily living at 1 to 4 months' follow-up (measured in various ways by 11 studies), or at 6 to 12 months' follow-up (13 studies). Long-term hip-related pain was not reported. Ambulatory setting: supported discharge and multidisciplinary home rehabilitation versus 'usual care' Three trials tested this comparison in 377 people mainly living at home. Due to very low-certainty evidence, we have very little confidence in the findings of little to no between-group difference in poor outcome (death or move to a higher level of care or inability to walk) at one year (3 studies); quality of life at one year (1 study); in mortality at 4 or 12 months (2 studies); in independence in personal activities of daily living (1 study); in moving permanently to a higher level of care (2 studies) or being unable to walk (2 studies). Long-term hip-related pain was not reported. One trial tested this comparison in 240 nursing home residents. There is low-certainty evidence that there may be no or minimal between-group differences at 12 months in 'poor outcome' defined as dead or unable to walk; or in mortality at 4 months or 12 months. Due to very low-certainty evidence, we have very little confidence in the findings of no between-group differences in dependency at 4 weeks or at 12 months, or in quality of life, inability to walk or pain at 12 months.

Authors' conclusions: In a hospital inpatient setting, there is moderate-certainty evidence that rehabilitation after hip fracture surgery, when delivered by a multidisciplinary team and supervised by an appropriate medical specialist, results in fewer cases of 'poor outcome' (death or deterioration in residential status). There is low-certainty evidence that multidisciplinary rehabilitation may result in fewer deaths in hospital and at 4 to 12 months; however, it may also result in slightly more. There is low-certainty evidence that multidisciplinary rehabilitation may reduce the numbers of people with poorer mobility at 12 months. No conclusions can be drawn on other outcomes, for which the evidence is of very low certainty. The generally very low-certainty evidence available for supported discharge and multidisciplinary home rehabilitation means that we are very uncertain whether the findings of little or no difference for all outcomes between the intervention and usual care is true. Given the prevalent clinical emphasis on early discharge, we suggest that research is best orientated towards early supported discharge and identifying the components of multidisciplinary inpatient rehabilitation to optimise patient recovery within hospital and the components of multidisciplinary rehabilitation, including social care, subsequent to hospital discharge.

Trial registration: ClinicalTrials.gov NCT01254942 NCT03906864 NCT00667914 NCT01052636 NCT01350557 NCT01051830 NCT01009268 NCT00000436 NCT03301584 NCT01435538 NCT00951691 NCT00962910.

Conflict of interest statement

None of the authors have a conflict of interest. As Ian Cameron was an investigator in three of the included trials, these trials were assessed independently by other review authors.

Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Figures

1
1
Hip fracture rehabilitation services – programme components (extract from Sheehan 2019)
2
2
Study flow diagram for the first phase of the search update 2009 to January 2016 (former scope)
3
3
Study flow diagram for the second phase of the search updates up to February/March 2019, November 2019 and October 2020 (revised scope)
4
4
Summary of review authors' assessments (+ = low; ? = unclear; ‐ = high risk of bias) for aspects of study conduct for individual trials
5
5
Multidisciplinary inpatient rehabilitation versus usual care: 'Poor outcome' (long‐term follow‐up at 6 or 12 months)
1.1. Analysis
1.1. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 1: 'Poor outcome' (long‐term follow‐up at 6 or 12 months)
1.2. Analysis
1.2. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 2: 'Poor outcome' (long‐term follow‐up): subgrouped by intervention type
1.3. Analysis
1.3. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 3: 'Poor outcome' (long‐term follow‐up) by selection bias
1.4. Analysis
1.4. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 4: 'Poor outcome' (at discharge)
1.5. Analysis
1.5. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 5: Mortality (end of scheduled follow‐up: 4 to 12 months)
1.6. Analysis
1.6. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 6: Mortality (end of scheduled follow‐up) ‐ with 12 month data for Cameron 1993
1.7. Analysis
1.7. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 7: Mortality (end of scheduled follow‐up): subgrouped by intervention type
1.8. Analysis
1.8. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 8: Mortality (at discharge)
1.9. Analysis
1.9. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 9: Quality of life: EQ‐5D (‐0.594: worse than death, 0: dead to 1: best quality)
1.10. Analysis
1.10. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 10: Quality of life: SF‐36 (Taiwan version) (each domain: 0 to 100; best quality) at 1 year
1.11. Analysis
1.11. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 11: Greater dependency in ADL up to 4 months
1.12. Analysis
1.12. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 12: Regain in former level of ADL independence in the short term (up to 4 months)
1.13. Analysis
1.13. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 13: Greater dependency in ADL in the long term (6 to 12 months)
1.14. Analysis
1.14. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 14: ADL: Barthel scores (higher scores = greater independence)
1.16. Analysis
1.16. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 16: Loss in activities of daily living at 6 months (Katz index; 6 maximum)
1.18. Analysis
1.18. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 18: Greater dependency in mobility
1.19. Analysis
1.19. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 19: Mobility: Short Physical Performance Battery (0 to 12: best mobility)
1.21. Analysis
1.21. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 21: Institutional care at 6 to 12 months (survivors)
1.22. Analysis
1.22. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 22: Complications
1.23. Analysis
1.23. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 23: Readmitted to hospital during follow‐up
1.24. Analysis
1.24. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 24: Dead or readmitted to hospital during follow‐up
1.25. Analysis
1.25. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 25: Length of hospital stay (days)
1.26. Analysis
1.26. Analysis
Comparison 1: Inpatient setting: multidisciplinary rehabilitation (MDR) versus usual care, Outcome 26: Subgroup analysis ‐ death at 12 months
2.1. Analysis
2.1. Analysis
Comparison 2: Inpatient setting: multidisciplinary rehabilitation (MDR) with an integrated care pathway versus MDR alone, Outcome 1: Poor outcome, dead, couldn't walk as before, or nursing home stay post discharge (12 months)
2.2. Analysis
2.2. Analysis
Comparison 2: Inpatient setting: multidisciplinary rehabilitation (MDR) with an integrated care pathway versus MDR alone, Outcome 2: SF‐12 scores at 12 months (0: worst to 100: best)
2.4. Analysis
2.4. Analysis
Comparison 2: Inpatient setting: multidisciplinary rehabilitation (MDR) with an integrated care pathway versus MDR alone, Outcome 4: Hospital readmission (at set times)
3.1. Analysis
3.1. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 1: 'Poor outcome', mortality, and unable to walk (3 or 4 months)
3.2. Analysis
3.2. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 2: 'Poor outcome', mortality, institutional care and unable to walk (12 months)
3.3. Analysis
3.3. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 3: Subgroup analysis: poor outcome (dead or non‐recovery of indoor walking ability) at 1 year, subgrouped by dementia status
3.4. Analysis
3.4. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 4: Subgroup analysis: mortality at 1 year, subgrouped by dementia status
3.5. Analysis
3.5. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 5: SF‐36 scores at 12 months (0: worst to 100: best)
3.6. Analysis
3.6. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 6: Independence in personal activities of daily living (PADL) and outdoor walking
3.9. Analysis
3.9. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 9: Complications (discharge to 12 months)
3.10. Analysis
3.10. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 10: Readmission to hospital and reoperation
3.11. Analysis
3.11. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 11: Falls outcomes
3.12. Analysis
3.12. Analysis
Comparison 3: Ambulatory setting: supported discharge and multidisciplinary home‐based rehabilitation versus usual inpatient rehabilitation, Outcome 12: Lengths of hospital or rehabilitation stays (days)
4.1. Analysis
4.1. Analysis
Comparison 4: Ambulatory setting: outreach multidisciplinary rehabilitation versus usual care in nursing homes, Outcome 1: 'Poor outcome', mortality, and unable to walk (12 months)
4.2. Analysis
4.2. Analysis
Comparison 4: Ambulatory setting: outreach multidisciplinary rehabilitation versus usual care in nursing homes, Outcome 2: All cause mortality
4.3. Analysis
4.3. Analysis
Comparison 4: Ambulatory setting: outreach multidisciplinary rehabilitation versus usual care in nursing homes, Outcome 3: Quality of life at 12 months: DEMQOL & DEMQOL‐Proxy
4.4. Analysis
4.4. Analysis
Comparison 4: Ambulatory setting: outreach multidisciplinary rehabilitation versus usual care in nursing homes, Outcome 4: EQ‐5D quality of life index at 12 months (0 dead to 1 best quality)
4.5. Analysis
4.5. Analysis
Comparison 4: Ambulatory setting: outreach multidisciplinary rehabilitation versus usual care in nursing homes, Outcome 5: Modified Barthel Index (0 to 100: total independence in personal care)
4.6. Analysis
4.6. Analysis
Comparison 4: Ambulatory setting: outreach multidisciplinary rehabilitation versus usual care in nursing homes, Outcome 6: Nursing Home Life‐Space Diameter (0 to 50; leaves facility daily)
4.7. Analysis
4.7. Analysis
Comparison 4: Ambulatory setting: outreach multidisciplinary rehabilitation versus usual care in nursing homes, Outcome 7: Pain: PAINAD (0 to 10; severe pain)
4.8. Analysis
4.8. Analysis
Comparison 4: Ambulatory setting: outreach multidisciplinary rehabilitation versus usual care in nursing homes, Outcome 8: Fall outcomes (adverse events)
5.1. Analysis
5.1. Analysis
Comparison 5: Ambulatory setting: intensive versus less intensive community rehabilitation, Outcome 1: 'Poor outcome', mortality and institutional care (12 months)
5.3. Analysis
5.3. Analysis
Comparison 5: Ambulatory setting: intensive versus less intensive community rehabilitation, Outcome 3: Number of contacts over 12 weeks (for participants with hip fracture or stroke)
6.1. Analysis
6.1. Analysis
Comparison 6: Ambulatory setting: extended multidisciplinary ambulatory rehabilitation versus usual care, Outcome 1: 'Poor outcome', mortality and institutional care (12 months)
6.2. Analysis
6.2. Analysis
Comparison 6: Ambulatory setting: extended multidisciplinary ambulatory rehabilitation versus usual care, Outcome 2: ALSAR: Assessment of Living Skills And Resources
7.1. Analysis
7.1. Analysis
Comparison 7: Outpatient multidisciplinary clinic between 3 to 12 months post fracture versus usual care, Outcome 1: Mortality and institutional care
8.1. Analysis
8.1. Analysis
Comparison 8: Exploratory analysis: inpatient and supported discharge (home‐based) settings, Outcome 1: 'Poor outcome' (long‐term follow‐up): subgrouped by intervention type
8.2. Analysis
8.2. Analysis
Comparison 8: Exploratory analysis: inpatient and supported discharge (home‐based) settings, Outcome 2: Mortality (end of scheduled follow‐up): subgrouped by intervention type

Source: PubMed

3
購読する